Top

Published in:

01-07-2008

Outsmarting the host: bacteria modulating the immune response

Authors: Matthew D. Woolard, Jeffrey A. Frelinger

Published in: Immunologic Research | Issue 3/2008

Abstract

Pathogenic bacteria and their hosts have had a two-way conversation for millions of years. This interaction has led to many measure/counter-measure responses by the host and bacteria. The host immune response has developed many mechanisms to neutralize and remove pathogen bacteria. In turn pathogenic bacteria have developed mechanisms to alter and evade the host immune response. We will review some of the mechanisms utilized by bacteria to accomplish this goal. We will also examine the current state of understanding of Francisella tularensis mediated immune evasion.

Zhou ZH, Zhang Y, Hu YF, Wahl LM, Cisar JO, Notkins AL. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe. 2007;1:51–61.PubMedCrossRef

Bessen DE. Localization of immunoglobulin A-binding sites within M or M-like proteins of group A streptococci. Infect Immun. 1994;62:1968–74.PubMed

Fagan PK, Reinscheid D, Gottschalk B, Chhatwal GS. Identification and characterization of a novel secreted immunoglobulin binding protein from group A streptococcus. Infect Immun. 2001;69:4851–7.PubMedCrossRef

Kawabata S, Tamura Y, Murakami J, Terao Y, Nakagawa I, Hamada S. A novel, anchorless streptococcal surface protein that binds to human immunoglobulins. Biochem Biophys Res Commun. 2002;296:1329–33.PubMedCrossRef

Senior BW, Woof JM. Effect of mutations in the human immunoglobulin A1 (IgA1) hinge on its susceptibility to cleavage by diverse bacterial IgA1 proteases. Infect Immun. 2005;73:1515–22.PubMedCrossRef

Lopez R. Pneumococcus: the sugar-coated bacteria. Int Microbiol. 2006;9:179–90.PubMed

Brown EJ, Joiner KA, Gaither TA, Hammer CH, Frank MM. The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J Immunol. 1983;131:409–15.PubMed

Cunnion KM, Lee JC, Frank MM. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun. 2001;69:6796–803.PubMedCrossRef

Schmidt CQ, Herbert AP, Hocking HG, Uhrin D, Barlow PN. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin Exp Immunol. 2008;151:14–24.PubMed

10.

Gulati S, Cox A, Lewis LA, Michael FS, Li J, Boden R, et al. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci. Infect Immun. 2005;73:7390–7.PubMedCrossRef

11.

Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, Pangburn MK, et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med. 1998;187:743–52.PubMedCrossRef

12.

Alitalo A, Meri T, Lankinen H, Seppala I, Lahdenne P, Hefty PS, et al. Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J Immunol. 2002;169:3847–53.PubMed

13.

Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem. 2001;276:8427–35.PubMedCrossRef

14.

Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710–20.PubMedCrossRef

15.

Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, Selsted ME. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest. 1989;84:553–61.PubMedCrossRef

16.

Guina T, Yi EC, Wang H, Hackett M, Miller SI. A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol. 2000;182:4077–86.PubMedCrossRef

17.

Kristian SA, Durr M, Van Strijp JA, Neumeister B, Peschel A. MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing. Infect Immun. 2003;71:546–9.PubMedCrossRef

18.

Oku Y, Kurokawa K, Ichihashi N, Sekimizu K. Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol. Microbiology. 2004;150:45–51.PubMedCrossRef

19.

Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med. 2001;193:1067–76.PubMedCrossRef

20.

Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol. 2005;3:36–46.PubMedCrossRef

21.

Kawasaki K, Ernst RK, Miller SI. Inhibition of Salmonella enterica serovar Typhimurium lipopolysaccharide deacylation by aminoarabinose membrane modification. J Bacteriol. 2005;187:2448–57.PubMedCrossRef

22.

Ernst RK, Guina T, Miller SI. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 2001;3:1327–34.PubMedCrossRef

23.

Ogawa T, Asai Y, Makimura Y, Tamai R. Chemical structure and immunobiological activity of Porphyromonas gingivalis lipid A. Front Biosci. 2007;12:3795–812.PubMedCrossRef

24.

Aepfelbacher M, Trasak C, Wilharm G, Wiedemann A, Trulzsch K, Krauss K, et al. Characterization of YopT effects on Rho GTPases in Yersinia enterocolitica-infected cells. J Biol Chem. 2003;278:33217–23.PubMedCrossRef

25.

Andor A, Trulzsch K, Essler M, Roggenkamp A, Wiedemann A, Heesemann J, et al. YopE of Yersinia, a GAP for Rho GTPases, selectively modulates Rac-dependent actin structures in endothelial cells. Cell Microbiol. 2001;3:301–10.PubMedCrossRef

26.

Mejia E, Bliska JB, Viboud GI. Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog. 2008;4:e3.PubMedCrossRef

27.

Viboud GI, Bliska JB. A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J. 2001;20:5373–82.PubMedCrossRef

28.

Monack DM, Mecsas J, Ghori N, Falkow S. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A. 1997;94:10385–90.PubMedCrossRef

29.

Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A. 2005;102:14046–51.PubMedCrossRef

30.

Lee CA, Silva M, Siber AM, Kelly AJ, Galyov E, McCormick BA. A secreted Salmonella protein induces a proinflammatory response in epithelial cells, which promotes neutrophil migration. Proc Natl Acad Sci U S A. 2000;97:12283–8.PubMedCrossRef

31.

Finbloom DS, Winestock KD. IL–10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol. 1995;155:1079–90.PubMed

32.

Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett. 2003;86:123–9.PubMedCrossRef

33.

Williams LM, Ricchetti G, Sarma U, Smallie T, Foxwell BM. Interleukin-10 suppression of myeloid cell activation–a continuing puzzle. Immunology. 2004;113:281–92.PubMedCrossRef

34.

Abramov VM, Khlebnikov VS, Vasiliev AM, Kosarev IV, Vasilenko RN, Kulikova NL, et al. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor. J Proteome Res. 2007;6:2222–31.PubMedCrossRef

35.

Sing A, Reithmeier-Rost D, Granfors K, Hill J, Roggenkamp A, Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc Natl Acad Sci U S A. 2005;102:16049–54.PubMedCrossRef

36.

McGuirk P, Mills KH. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis. Eur J Immunol. 2000;30:415–22.PubMedCrossRef

37.

Hybiske K, Stephens RS. Exit strategies of intracellular pathogens. Nat Rev Microbiol. 2008;6:99–110.PubMedCrossRef

38.

Joseph B, Goebel W. Life of Listeria monocytogenes in the host cells’ cytosol. Microbes Infect. 2007;9:1188–95.PubMedCrossRef

39.

Ogawa M, Sasakawa C. Intracellular survival of Shigella. Cell Microbiol. 2006;8:177–84.PubMedCrossRef

40.

Santic M, Molmeret M, Klose KE, Abu Kwaik Y. Francisella tularensis travels a novel, twisted road within macrophages. Trends Microbiol. 2006;14:37–44.PubMedCrossRef

41.

Underhill DM. Phagosome maturation: steady as she goes. Immunity. 2005;23:343–44.PubMedCrossRef

42.

Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev. 2007;219:37–54.PubMedCrossRef

43.

Saleh MT, Belisle JT. Secretion of an acid phosphatase (SapM) by Mycobacterium tuberculosis that is similar to eukaryotic acid phosphatases. J Bacteriol. 2000;182:6850–3.PubMedCrossRef

44.

Vergne I, Chua J, Lee HH, Lucas M, Belisle J, Deretic V. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2005;102:4033–8.PubMedCrossRef

45.

Vergne I, Fratti RA, Hill PJ, Chua J, Belisle J, Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: mycobacterial phosphatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol Biol Cell. 2004;15:751–60.PubMedCrossRef

46.

Harrison RE, Brumell JH, Khandani A, Bucci C, Scott CC, Jiang X, et al. Salmonella impairs RILP recruitment to Rab7 during maturation of invasion vacuoles. Mol Biol Cell. 2004;15:3146–54.PubMedCrossRef

47.

Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection. Infect Immun. 1992;60:5013–6.PubMed

48.

Ramachandra L, Noss E, Boom WH, Harding CV. Phagocytic processing of antigens for presentation by class II major histocompatibility complex molecules. Cell Microbiol. 1999;1:205–14.PubMedCrossRef

49.

Pennini ME, Liu Y, Yang J, Croniger CM, Boom WH, Harding CV. CCAAT/enhancer-binding protein beta and delta binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein. J Immunol. 2007;179:6910–18.PubMed

50.

Shaw AC, Vandahl BB, Larsen MR, Roepstorff P, Gevaert K, Vandekerckhove J, et al. Characterization of a secreted Chlamydia protease. Cell Microbiol. 2002;4:411–24.PubMedCrossRef

51.

Zhong G, Fan P, Ji H, Dong F, Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med. 2001;193:935–42.PubMedCrossRef

52.

Zhong G, Liu L, Fan T, Fan P, Ji, H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J Exp Med. 2000;191:1525–34.PubMedCrossRef

53.

Villard J, Peretti M, Masternak K, Barras E, Caretti G, Mantovani R, et al. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol Cell Biol. 2000;20:3364–76.PubMedCrossRef

54.

Muhlethaler-Mottet A, Di Berardino W, Otten LA, Mach B. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity. 1998;8:157–66.PubMedCrossRef

55.

Mason CM, Porretta E, Zhang P, Nelson S. CD4 + CD25 + transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Clin Exp Immunol. 2007;148:537–45.PubMed

56.

Al-Ramadi BK, Brodkin MA, Mosser DM, Eisenstein TK. Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors. J Immunol. 1991;146:2737–46.PubMed

57.

Eisenstein TK, Dalal N, Killar L, Lee JC, Schafer R. Paradoxes of immunity and immunosuppression in Salmonella infection. Adv Exp Med Biol. 1988;239:353–66.PubMed

58.

Lee JC, Gibson CW, Eisenstein TK. Macrophage-mediated mitogenic suppression induced in mice of the C3H lineage by a vaccine strain of Salmonella typhimurium. Cell Immunol. 1985;91:75–91.PubMedCrossRef

59.

Gerke C, Falkow S, Chien YH. The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J Exp Med. 2005;201:361–71.PubMedCrossRef

60.

Paccani SR, Tonello F, Ghittoni R, Natale M, Muraro L, D’Elios MM, et al. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J Exp Med. 2005;201:325–31.PubMedCrossRef

61.

Baldari CT, Tonello F, Paccani SR, Montecucco C. Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 2006;27:434–40.PubMedCrossRef

62.

Wang J, Brooks EG, Bamford KB, Denning TL, Pappo J, Ernst PB. Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immunol. 2001;167:926–34.PubMed

63.

Alibek K, Handelman S. Biohazard: the chilling true story of the largest covert biological weapons program in the world—told from the Inside by the man who ran it. New York: Delta (Random House); 2000.

64.

Charity JC, Costante-Hamm MM, Balon EL, Boyd DH, Rubin EJ, Dove SL. Twin RNA polymerase-associated proteins control virulence gene expression in Francisella tularensis. PLoS Pathog. 2007;3:e84.PubMedCrossRef

65.

Lauriano CM, Barker JR, Yoon SS, Nano FE, Arulanandam BP, Hassett DJ, et al. MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc Natl Acad Sci U S A. 2004;101:4246–9.PubMedCrossRef

66.

Kieffer TL, Cowley S, Nano FE, Elkins KL. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis. Microbes Infect. 2003;5:397–403.PubMedCrossRef

67.

Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, Edebro H, et al. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect Immun. 2006;74:6730–8.PubMedCrossRef

68.

Phillips NJ, Schilling B, McLendon MK, Apicella MA, Gibson BW. Novel modification of lipid A of Francisella tularensis. Infect Immun. 2004;72:5340–8.PubMedCrossRef

69.

Vinogradov E, Perry MB, Conlan JW. Structural analysis of Francisella tularensis lipopolysaccharide. Eur J Biochem. 2002;269:6112–8.PubMedCrossRef

70.

Wang X, McGrath SC, Cotter RJ, Raetz CR. Expression cloning and periplasmic orientation of the Francisella novicida lipid A 4’-phosphatase LpxF. J Biol Chem. 2006;281:9321–30.PubMedCrossRef

71.

Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, et al. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS. Microbiology. 2007;153:3141–53.PubMedCrossRef

72.

Thomas RM, Titball RW, Oyston PC, Griffin K, Waters E, Hitchen PG, et al. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Infect Immun. 2007;75:371–8.PubMedCrossRef

73.

Ben Nasr A, Klimpel GR. Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J Leukoc Biol. 2008;94:1–9.

74.

Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J Leukoc Biol. 2006;80:774–86.PubMedCrossRef

75.

Clemens DL, Lee BY, Horwitz MA. Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun. 2005;73:5892–902.PubMedCrossRef

76.

Pierini LM. Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell Microbiol. 2006;8:1361–70.PubMedCrossRef

77.

Telepnev M, Golovliov I, Grundstrom T, Tarnvik A, Sjostedt A. Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell Microbiol. 2003;5:41–51.PubMedCrossRef

78.

Telepnev M, Golovliov I, Sjostedt A. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb Pathog. 2005;38:239–47.PubMedCrossRef

79.

Bosio CM, Dow SW. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol. 2005;175:6792–801.PubMed

80.

Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, Drake JR, et al. Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J Immunol. 2007;178:2065–74.PubMed

81.

D’Acquisto F, Sautebin L, Iuvone T, Di Rosa M, Carnuccio R. Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. FEBS Lett. 1998;440:76–80.PubMedCrossRef

82.

Lindgren H, Stenman L, Tarnvik A, Sjostedt A. The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages. Microbes Infect. 2005;7:467–75.PubMedCrossRef

83.

Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem. 1988;263:5380–4.PubMed

84.

Cowley SC, Elkins KL. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med. 2003;198:379–89.PubMedCrossRef

85.

Cowley SC, Sedgwick JD, Elkins KL. Differential requirements by CD4 + and CD8 + T cells for soluble and membrane TNF in control of Francisella tularensis live vaccine strain intramacrophage growth. J Immunol. 2007;179:7709–19.PubMed

86.

Woolard MD, Hensley LL, Kawula TH, Frelinger JA. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect Immun. 2008;76:2651–9.PubMedCrossRef

Title: Outsmarting the host: bacteria modulating the immune response
Authors: Matthew D. Woolard
Jeffrey A. Frelinger
Publication date: 01-07-2008
Publisher: Humana Press Inc
Published in: Immunologic Research / Issue 3/2008
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-008-8021-5

At a glance: The STEP trials

Springer Medicine

Outsmarting the host: bacteria modulating the immune response

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2008

Anti-Sm B cell tolerance and tolerance loss in systemic lupus erythematosus

TCR-MHC docking orientation: natural selection, or thymic selection?

Parameters influencing antigen-specific immunotherapy for type 1 diabetes

Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response

The regulation of autoreactive B cells during innate immune responses

Microglial cells and Parkinson’s disease